Initiating basal insulin in type 2 diabetes mellitus

Published on 20 Nov 2017
Last Updated on 29 Nov 2024

This ACE Clinical Guidance (ACG) highlights the importance of not delaying insulin therapy for patients with type 2 diabetes mellitus and offers a practical guide on initiating basal insulin. It also provides evidence-based practice points on how to prevent and manage hypoglycaemia. First published in 2017, this ACG been updated in 2024 to reflect recent changes in insulin product availability and incorporate the latest evidence where relevant. 

Download the ACG

Initiating basal insulin in type 2 diabetes mellitus (Nov 2024) [PDF]

ACG recommendations

1. Start basal insulin if glycaemic targets are not met despite optimal treatment with non-insulin T2DM medications.

2. Review concomitant T2DM medications when starting basal insulin and continue them at the current or lower dose where appropriate.

3. Educate patients and their caregivers on how to use insulin safely and effectively, including how to prevent and manage hypoglycaemia. 

ACG references

Initiating basal insulin in type 2 diabetes mellitus references (Nov 2024) [PDF]